| John I Hogan, MD | |
|
222 Station Plz N Ste 432, Mineola, NY 11501-3893 | |
| (516) 663-2507 | |
| Not Available |
| Full Name | John I Hogan |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 12 Years |
| Location | 222 Station Plz N Ste 432, Mineola, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033473590 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | L-251714 (Massachusetts) | Secondary |
| 207RI0200X | Internal Medicine - Infectious Disease | 0101264971 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
Napping beyond the age of 2 is linked to poorer sleep quality in young children, although the impact on behaviour and development is less clear-cut, finds an analysis of the available evidence published online in Archives of Disease in Childhood.
Significantly more children get health insurance coverage after increases in federal matching funds to states for Medicaid and the Children's Health Insurance Program (CHIP), according to new research from the University of Michigan.
PARI Pharma has enrolled the first patient in its Phase 2b clinical trial studying inhaled liposomal cyclosporine A (L-CsA) delivered via a customized Investigational eFlow Nebulizer System. The multinational study is investigating the safety and efficacy of PARI's L-CsA formulation. In previous clinical trials, reactions from physicians and lung transplant recipients to PARI's drug-device combination were encouraging.
"A proliferation of complex challenges to development, such as political conflict, economic austerity, and environmental degradation, all demand attention, but should not deflect from recognizing that good health is central to advancing global prosperity," GAVI Alliance CEO Seth Berkley, WHO Director-General Margaret Chan, Global Fund to Fight AIDS, TB and Malaria Executive Director Mark Dybul, World Bank Sector Manager for Health in Latin America Keith Hansen, UNICEF Executive Director Anthony Lake, UNFPA Executive Director Babatunde Osotimehin, and UNAIDS Executive Director Michel Sidibé, write in a Lancet opinion piece examining the post-2015 development agenda.
› Verified 1 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
Napping beyond the age of 2 is linked to poorer sleep quality in young children, although the impact on behaviour and development is less clear-cut, finds an analysis of the available evidence published online in Archives of Disease in Childhood.
Significantly more children get health insurance coverage after increases in federal matching funds to states for Medicaid and the Children's Health Insurance Program (CHIP), according to new research from the University of Michigan.
PARI Pharma has enrolled the first patient in its Phase 2b clinical trial studying inhaled liposomal cyclosporine A (L-CsA) delivered via a customized Investigational eFlow Nebulizer System. The multinational study is investigating the safety and efficacy of PARI's L-CsA formulation. In previous clinical trials, reactions from physicians and lung transplant recipients to PARI's drug-device combination were encouraging.
"A proliferation of complex challenges to development, such as political conflict, economic austerity, and environmental degradation, all demand attention, but should not deflect from recognizing that good health is central to advancing global prosperity," GAVI Alliance CEO Seth Berkley, WHO Director-General Margaret Chan, Global Fund to Fight AIDS, TB and Malaria Executive Director Mark Dybul, World Bank Sector Manager for Health in Latin America Keith Hansen, UNICEF Executive Director Anthony Lake, UNFPA Executive Director Babatunde Osotimehin, and UNAIDS Executive Director Michel Sidibé, write in a Lancet opinion piece examining the post-2015 development agenda.
› Verified 1 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Napping beyond the age of 2 is linked to poorer sleep quality in young children, although the impact on behaviour and development is less clear-cut, finds an analysis of the available evidence published online in Archives of Disease in Childhood.
Significantly more children get health insurance coverage after increases in federal matching funds to states for Medicaid and the Children's Health Insurance Program (CHIP), according to new research from the University of Michigan.
PARI Pharma has enrolled the first patient in its Phase 2b clinical trial studying inhaled liposomal cyclosporine A (L-CsA) delivered via a customized Investigational eFlow Nebulizer System. The multinational study is investigating the safety and efficacy of PARI's L-CsA formulation. In previous clinical trials, reactions from physicians and lung transplant recipients to PARI's drug-device combination were encouraging.
"A proliferation of complex challenges to development, such as political conflict, economic austerity, and environmental degradation, all demand attention, but should not deflect from recognizing that good health is central to advancing global prosperity," GAVI Alliance CEO Seth Berkley, WHO Director-General Margaret Chan, Global Fund to Fight AIDS, TB and Malaria Executive Director Mark Dybul, World Bank Sector Manager for Health in Latin America Keith Hansen, UNICEF Executive Director Anthony Lake, UNFPA Executive Director Babatunde Osotimehin, and UNAIDS Executive Director Michel Sidibé, write in a Lancet opinion piece examining the post-2015 development agenda.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John I Hogan, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: (434) 295-1000 | John I Hogan, MD 222 Station Plz N Ste 432, Mineola, NY 11501-3893 Ph: (516) 663-2507 |
News Archive
Napping beyond the age of 2 is linked to poorer sleep quality in young children, although the impact on behaviour and development is less clear-cut, finds an analysis of the available evidence published online in Archives of Disease in Childhood.
Significantly more children get health insurance coverage after increases in federal matching funds to states for Medicaid and the Children's Health Insurance Program (CHIP), according to new research from the University of Michigan.
PARI Pharma has enrolled the first patient in its Phase 2b clinical trial studying inhaled liposomal cyclosporine A (L-CsA) delivered via a customized Investigational eFlow Nebulizer System. The multinational study is investigating the safety and efficacy of PARI's L-CsA formulation. In previous clinical trials, reactions from physicians and lung transplant recipients to PARI's drug-device combination were encouraging.
"A proliferation of complex challenges to development, such as political conflict, economic austerity, and environmental degradation, all demand attention, but should not deflect from recognizing that good health is central to advancing global prosperity," GAVI Alliance CEO Seth Berkley, WHO Director-General Margaret Chan, Global Fund to Fight AIDS, TB and Malaria Executive Director Mark Dybul, World Bank Sector Manager for Health in Latin America Keith Hansen, UNICEF Executive Director Anthony Lake, UNFPA Executive Director Babatunde Osotimehin, and UNAIDS Executive Director Michel Sidibé, write in a Lancet opinion piece examining the post-2015 development agenda.
› Verified 1 days ago
Dr. Marlene Martins Lobato, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 173 Mineola Blvd, Suite 403, Mineola, NY 11501 Phone: 516-741-8891 Fax: 516-741-8829 | |
Michael Garrison, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Old Country Rd, Suite 450, Mineola, NY 11501 Phone: 516-663-9500 Fax: 516-663-4613 | |
Dr. Anupama Ananda, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 190 Willis Ave, Suite 210, Mineola, NY 11501 Phone: 516-739-7290 Fax: 516-793-7291 | |
Mr. Jeffrey Liu, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 297 Mineola Blvd, Mineola, NY 11501 Phone: 516-294-1377 Fax: 516-294-5574 | |
Dr. Jonathan Shulman, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-2381 | |
Dr. Anthony Massimillo, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Old Country Rd Ste 31, Mineola, NY 11501 Phone: 516-294-9380 Fax: 516-294-5351 |